Neurological & Psychological Disorders
News on research and diagnostic developments in neuroscience.
Merck Acquiring Caraway Therapeutics for Precision Neurodegenerative, Rare Disease Drugs
In the deal valued at $610 million, Caraway will be able to leverage Merck's R&D resources to advance its early-stage therapies.
Octave Bioscience Wins $10M Grant From Michael J. Fox Foundation
The firm will use the funds to develop a protein panel that can help assess disease activity and progression in individuals with Parkinson's.
PGx-Guided Depression Treatment Could Save Canadian Province C$956M Over 20 Years, Study Suggests
Premium
A new analysis suggests the cost of setting up PGx testing in British Columbia may be quickly offset due to fewer patients with treatment-resistant depression.
Amydis Nabs $3.4M NIH Grant to Develop Retinal Biomarkers for Alzheimer's
The San Diego-based firm will use its fluorescent ocular tracers to create a retinal biomarker database of Alzheimer's pathogenesis.
Grace Science to Start Phase I/II/III Trial for Gene Therapy in NGLY1 Deficiency
The firm will begin enrolling pediatric patients with the debilitating neurological disease into the open-label, single-arm study.